MCID: BRD004
MIFTS: 51

Borderline Personality Disorder

Categories: Mental diseases

Aliases & Classifications for Borderline Personality Disorder

MalaCards integrated aliases for Borderline Personality Disorder:

Name: Borderline Personality Disorder 12 75 55 44 15 72

Classifications:



External Ids:

Disease Ontology 12 DOID:10930
ICD9CM 35 301.83
MeSH 44 D001883
NCIt 50 C92633
SNOMED-CT 68 20010003
ICD10 33 F60.3
UMLS 72 C0006012

Summaries for Borderline Personality Disorder

Disease Ontology : 12 A personality disorder that involves a prolonged disturbance of personality function characterized by depth and variability of moods.

MalaCards based summary : Borderline Personality Disorder is related to avoidant personality disorder and alexithymia. An important gene associated with Borderline Personality Disorder is SLC6A4 (Solute Carrier Family 6 Member 4), and among its related pathways/superpathways are Peptide ligand-binding receptors and cAMP signaling pathway. The drugs Citalopram and Lamotrigine have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and amygdala, and related phenotypes are behavior/neurological and homeostasis/metabolism

Wikipedia : 75 Borderline personality disorder (BPD), also known as emotionally unstable personality disorder (EUPD),... more...

Related Diseases for Borderline Personality Disorder

Diseases related to Borderline Personality Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 207, show less)
# Related Disease Score Top Affiliating Genes
1 avoidant personality disorder 32.2 TPH1 SLC6A4 MAOA
2 alexithymia 31.1 SLC6A4 HTR1A COMT
3 dysthymic disorder 31.0 SLC6A4 MAOA HTR2A
4 antisocial personality disorder 30.8 SLC6A4 MAOA HTR1B COMT
5 eating disorder 30.8 SLC6A4 HTR2C COMT BDNF
6 traumatic brain injury 30.7 COMT BDNF
7 conduct disorder 30.7 TPH1 SLC6A4 MAOA COMT
8 oppositional defiant disorder 30.6 SLC6A4 MAOA COMT
9 agoraphobia 30.6 SLC6A4 MAOA HTR1A
10 phobia, specific 30.6 MAOA COMT
11 intermittent explosive disorder 30.5 SLC6A4 PRL HTR1A
12 substance dependence 30.4 SLC6A4 MAOA HTR1B BDNF
13 atypical depressive disorder 30.4 SLC6A4 MAOA HTR2A
14 schizophreniform disorder 30.4 PRL COMT
15 bipolar disorder 30.3 TPH1 SLC6A4 HTR2A HTR1A COMT BDNF
16 social phobia 30.3 SLC6A4 PRL MAOA HTR1A
17 bulimia nervosa 30.2 SLC6A4 HTR2A HTR1B COMT BDNF
18 substance abuse 30.2 SLC6A4 PRL MAOA HTR1B COMT BDNF
19 tardive dyskinesia 30.2 HTR2A COMT
20 anorexia nervosa 30.2 SLC6A4 PRL HTR2A COMT BDNF
21 substance-induced psychosis 30.2 HTR2A HTR1A
22 sexual disorder 30.2 SLC6A4 PRL HTR1A
23 fibromyalgia 30.2 SLC6A4 PRL HTR2A COMT
24 amnestic disorder 30.2 HTR1A BDNF
25 paraphilia disorder 30.0 PRL MAOA
26 schizoaffective disorder 30.0 SLC6A4 PRL HTR2A COMT BDNF
27 panic disorder 29.9 SLC6A4 MAOA HTR2A HTR1A COMT
28 tobacco addiction 29.7 TPH1 SLC6A4 MAOA HTR2A COMT
29 autism spectrum disorder 29.5 SLC6A4 HTR2A BDNF AVPR1A
30 postpartum depression 29.4 SLC6A4 PRL MAOA COMT BDNF
31 paranoid schizophrenia 29.2 SLC6A4 MAOA HTR2A COMT BDNF
32 autism 29.1 SLC6A4 HTR2A HTR1A BDNF AVPR1A
33 generalized anxiety disorder 29.1 TPH1 SLC6A4 MAOA HTR2A HTR1A COMT
34 bipolar i disorder 29.0 SLC6A4 HTR2C HTR2A HTR1A COMT BDNF
35 psychotic disorder 28.6 TPH1 SLC6A4 PRL HTR2C HTR2A HTR1A
36 disease of mental health 28.6 SLC6A4 MAOA HTR2C HTR2A HTR1A COMT
37 post-traumatic stress disorder 28.6 SLC6A4 NR3C1 MAOA HTR2A FKBP5 COMT
38 depression 28.4 TPH1 SLC6A4 NR3C1 MAOA HTR2C HTR2A
39 personality disorder 28.4 TPH1 SLC6A4 PRL MAOA HTR2C HTR2A
40 endogenous depression 28.2 TPH1 SLC6A4 NR3C1 MAOA HTR2A HTR1A
41 attention deficit-hyperactivity disorder 28.2 TPH1 SLC6A4 MAOA HTR2C HTR2A HTR1B
42 chronic fatigue syndrome 27.9 SLC6A4 NR3C1 MAOA HTR2A HTR1A COMT
43 alcohol dependence 27.7 TPH1 SLC6A4 MAOA HTR2C HTR2A HTR1B
44 anxiety 27.6 TPH1 SLC6A4 NR3C1 MAOA HTR2C HTR2A
45 obsessive-compulsive disorder 27.2 TPH1 SLC6A4 PRL MAOA HTR2C HTR2A
46 mental depression 27.2 TPH1 SLC6A4 NR3C1 MAOA HTR2C HTR2A
47 migraine with or without aura 1 27.2 TPH1 SLC6A4 MAOA HTR2C HTR2A HTR1B
48 mood disorder 27.0 TPH1 SLC6A4 NR3C1 MAOA HTR2C HTR2A
49 schizophrenia 26.9 TPH1 SLC6A4 PRL MAOA HTR2C HTR2A
50 major depressive disorder 26.1 TPH1 SLC6A4 PRL NR3C1 MAOA HTR2C
51 multiple personality disorder 11.6
52 impulse control disorder 11.2
53 major affective disorder 8 10.9
54 major affective disorder 9 10.9
55 severe combined immunodeficiency 10.8
56 acute stress disorder 10.6
57 schizotypal personality disorder 10.5
58 alcohol use disorder 10.5
59 depersonalization disorder 10.5
60 pseudobulbar affect 10.4
61 early-onset schizophrenia 10.4 HTR2A BDNF
62 mammographic density 10.4 PRL COMT
63 allergic hypersensitivity disease 10.4
64 narcissistic personality disorder 10.4
65 alcoholic psychosis 10.4 SLC6A4 HTR2A
66 chronic pain 10.3
67 schizoid personality disorder 10.3 HTR2A HTR1A
68 hypoactive sexual desire disorder 10.3 HTR2A HTR1A
69 major affective disorder 1 10.3
70 somatization disorder 10.3
71 specific developmental disorder 10.3 SLC6A4 COMT BDNF
72 dystonia 1, torsion, autosomal dominant 10.3 MAOA COMT
73 dissociative disorder 10.3
74 somatoform disorder 10.3
75 sleep disorder 10.3
76 drug dependence 10.3
77 migraine without aura 10.2 SLC6A4 PRL HTR1A
78 drug psychosis 10.2 HTR2A HTR1A
79 hand skill, relative 10.2
80 obsessive-compulsive personality disorder 10.2
81 drug-induced mental disorder 10.2 HTR2A HTR1A
82 kleptomania 10.2 SLC6A4 MAOA HTR1A
83 smoking as a quantitative trait locus 3 10.2
84 dissociative amnesia 10.2
85 hypochondriasis 10.2
86 cyclothymic disorder 10.2
87 pathological gambling 10.2 SLC6A4 MAOA HTR2A
88 central nervous system disease 10.1 SLC6A4 HTR2A BDNF
89 body dysmorphic disorder 10.1
90 polycystic ovary syndrome 10.1
91 neurotic disorder 10.1
92 heroin dependence 10.1
93 47,xyy 10.1
94 body mass index quantitative trait locus 1 10.1
95 alacrima, achalasia, and mental retardation syndrome 10.1
96 macular dystrophy with central cone involvement 10.1
97 dependent personality disorder 10.1
98 paranoid personality disorder 10.1
99 syphilis 10.1
100 kleine-levin hibernation syndrome 10.1 TPH1 COMT
101 ocular dominance 10.0 HTR2C BDNF
102 nelson syndrome 10.0 PRL NR3C1
103 galactorrhea 10.0
104 paine syndrome 10.0
105 schizophrenia 2 10.0
106 bone mineral density quantitative trait locus 3 10.0
107 sexual sadism 10.0
108 sexual masochism 10.0
109 chlamydia 10.0
110 dementia 10.0
111 cannabis dependence 10.0
112 melancholia 10.0
113 temporal lobe epilepsy 10.0
114 histrionic personality disorder 10.0
115 pituitary adenoma 10.0
116 movement disease 10.0
117 premenstrual tension 10.0
118 genital herpes 10.0
119 learning disability 10.0
120 cocaine dependence 10.0
121 depersonalization/derealization disorder 10.0
122 brain injury 10.0
123 headache 10.0
124 hypersomnia 10.0
125 pik3ca-related overgrowth syndrome 10.0
126 phobic disorder 9.9 SLC6A4 MAOA HTR1A COMT
127 acth-secreting pituitary adenoma 9.9 PRL NR3C1
128 pulmonary hypertension 9.9 TPH1 SLC6A4 HTR1B
129 serotonin syndrome 9.8 SLC6A4 MAOA HTR2A HTR1A
130 diabetes mellitus, noninsulin-dependent 9.8
131 gilles de la tourette syndrome 9.8
132 hypertriglyceridemia, familial 9.8
133 lithium transport 9.8
134 parastremmatic dwarfism 9.8
135 albinism, oculocutaneous, type ii 9.8
136 maple syrup urine disease 9.8
137 schizencephaly 9.8
138 aging 9.8
139 frontotemporal dementia 9.8
140 pituitary adenoma, prolactin-secreting 9.8
141 transsexuality 9.8
142 acromelic frontonasal dysostosis 9.8
143 polysubstance abuse 9.8
144 resting heart rate, variation in 9.8
145 brachydactyly-syndactyly syndrome 9.8
146 major affective disorder 5 9.8
147 major affective disorder 6 9.8
148 trichotillomania 9.8
149 leukemia, acute lymphoblastic 3 9.8
150 hyperprolactinemia 9.8
151 schizophrenia 19 9.8
152 deficiency anemia 9.8
153 restless legs syndrome 9.8
154 asperger syndrome 9.8
155 exanthem 9.8
156 chorioamnionitis 9.8
157 sleep apnea 9.8
158 withdrawal disorder 9.8
159 pervasive developmental disorder 9.8
160 aphasia 9.8
161 pain agnosia 9.8
162 physical disorder 9.8
163 asymptomatic neurosyphilis 9.8
164 separation anxiety disorder 9.8
165 transsexualism 9.8
166 anogenital venereal wart 9.8
167 gestational diabetes 9.8
168 visual epilepsy 9.8
169 goiter 9.8
170 gender identity disorder 9.8
171 ehlers-danlos syndrome 9.8
172 bird fancier's lung 9.8
173 amenorrhea 9.8
174 hypothyroidism 9.8
175 factitious disorder 9.8
176 impotence 9.8
177 trichomoniasis 9.8
178 constipation 9.8
179 arteriosclerosis 9.8
180 opiate dependence 9.8
181 dermatitis 9.8
182 tic disorder 9.8
183 lipid metabolism disorder 9.8
184 hyperglycemia 9.8
185 adjustment disorder 9.8
186 human immunodeficiency virus infectious disease 9.8
187 anterograde amnesia 9.8
188 adenoma 9.8
189 delusional disorder 9.8
190 hyperthyroidism 9.8
191 subacute delirium 9.8
192 hypermobile ehlers-danlos syndrome 9.8
193 charles bonnet syndrome 9.8
194 neurosyphilis 9.8
195 opioid addiction 9.8
196 head injury 9.8
197 seizure disorder 9.8
198 arterial thoracic outlet syndrome 9.8
199 rhombencephalosynapsis 9.8
200 schizophrenia 5 9.8 HTR2C HTR2A HTR1A
201 adrenal cortex disease 9.7 PRL NR3C1
202 psychosexual disorder 9.6 SLC6A4 HTR2C HTR2A HTR1A
203 periodic limb movement disorder 9.6 SLC6A4 HTR2C HTR2A HTR1A
204 premature ejaculation 9.5 SLC6A4 HTR2C HTR1B HTR1A
205 sudden infant death syndrome 9.3 TPH1 SLC6A4 MAOA HTR2A HTR1A BDNF
206 parkinson disease, late-onset 9.3 SLC6A4 MAOA HTR2A HTR1A COMT BDNF
207 brunner syndrome 9.3 TPH1 SLC6A4 MAOA HTR1B HTR1A COMT

Comorbidity relations with Borderline Personality Disorder via Phenotypic Disease Network (PDN): (showing 9, show less)


Acute Cystitis Anxiety
Cerebral Atherosclerosis Dependent Personality Disorder
Dysthymic Disorder Hypertension, Essential
Hypothyroidism Major Depressive Disorder
Schizophreniform Disorder

Graphical network of the top 20 diseases related to Borderline Personality Disorder:



Diseases related to Borderline Personality Disorder

Symptoms & Phenotypes for Borderline Personality Disorder

MGI Mouse Phenotypes related to Borderline Personality Disorder:

46 (showing 7, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.22 AVPR1A BDNF COMT FKBP5 HTR1A HTR1B
2 homeostasis/metabolism MP:0005376 10 AVPR1A BDNF COMT FKBP5 HTR1A HTR2C
3 cardiovascular system MP:0005385 9.97 AVPR1A COMT HTR1A HTR1B MAOA NR3C1
4 endocrine/exocrine gland MP:0005379 9.92 AVPR1A BDNF COMT HTR1B HTR2A NR3C1
5 integument MP:0010771 9.63 BDNF HTR2C NR3C1 PRL SLC6A4 TPH1
6 muscle MP:0005369 9.5 AVPR1A HTR1B HTR2A HTR2C NR3C1 SLC6A4
7 nervous system MP:0003631 9.28 AVPR1A BDNF COMT HTR1A HTR2C MAOA

Drugs & Therapeutics for Borderline Personality Disorder

Drugs for Borderline Personality Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 127, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Citalopram Approved Phase 4 59729-33-8 2771
2
Lamotrigine Approved, Investigational Phase 4 84057-84-1 3878
3
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
4
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
5
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
6
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
7 Omega 3 Fatty Acid Phase 4
8 Neurotransmitter Agents Phase 4
9 Serotonin Uptake Inhibitors Phase 4
10 Peripheral Nervous System Agents Phase 4
11 Neurotransmitter Uptake Inhibitors Phase 4
12 Serotonin Agents Phase 4
13 Autonomic Agents Phase 4
14 Parasympatholytics Phase 4
15 Antidepressive Agents Phase 4
16 Antidepressive Agents, Second-Generation Phase 4
17 Cholinergic Agents Phase 4
18 Muscarinic Antagonists Phase 4
19 Cholinergic Antagonists Phase 4
20 Antiparkinson Agents Phase 4
21 Diuretics, Potassium Sparing Phase 4
22 Sodium Channel Blockers Phase 4
23 Calcium, Dietary Phase 4
24 calcium channel blockers Phase 4
25 Dopamine Agents Phase 4
26 Serotonin Antagonists Phase 4
27 Dopamine Antagonists Phase 4
28 Cytochrome P-450 CYP2D6 Inhibitors Phase 4
29 Cytochrome P-450 Enzyme Inhibitors Phase 4
30
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
31
Rifaximin Approved, Investigational Phase 2, Phase 3 80621-81-4 46783403 6436173
32
Olanzapine Approved, Investigational Phase 3 132539-06-1 4585
33
Selegiline Approved, Investigational, Vet_approved Phase 3 14611-51-9 5195 26757
34
Naltrexone Approved, Investigational, Vet_approved Phase 3 16590-41-3 5360515
35 Sulfalene Phase 2, Phase 3
36 Antibiotics, Antitubercular Phase 2, Phase 3
37 Antitubercular Agents Phase 2, Phase 3
38 Anti-Bacterial Agents Phase 2, Phase 3
39 Antiemetics Phase 3
40 Gastrointestinal Agents Phase 3
41 Tranquilizing Agents Phase 3
42 Quetiapine Fumarate Phase 3 111974-72-2
43 Narcotics Phase 3
44 Narcotic Antagonists Phase 3
45 Analgesics, Opioid Phase 3
46
Acetaminophen Approved Phase 2 103-90-2 1983
47
Ziprasidone Approved Phase 2 146939-27-7 60854
48
Lithium carbonate Approved Phase 2 554-13-2
49
Cocaine Approved, Illicit Phase 2 50-36-2 446220 5760
50
Oxytocin Approved, Vet_approved Phase 2 50-56-6 439302 53477758
51
Acetylcholine Approved, Investigational Phase 2 51-84-3 187
52
Brexpiprazole Approved, Investigational Phase 2 913611-97-9 11978813
53
Midazolam Approved, Illicit Phase 2 59467-70-8 4192
54
Ketamine Approved, Vet_approved Phase 2 6740-88-1 3821
55
Hydrocortisone acetate Approved, Vet_approved Phase 2 50-03-3
56
Hydrocortisone Approved, Vet_approved Phase 2 50-23-7 5754
57
Mifepristone Approved, Investigational Phase 2 84371-65-3 55245
58
Acetylcysteine Approved, Investigational Phase 2 616-91-1 12035
59
Glutamic acid Approved, Nutraceutical Phase 2 56-86-0 33032
60 Analgesics, Non-Narcotic Phase 2
61 Antipyretics Phase 2
62 Antimanic Agents Phase 2
63 Pharmaceutical Solutions Phase 2
64 GABA Agents Phase 2
65 Oxytocics Phase 2
66 abobotulinumtoxinA Phase 2
67 Neuromuscular Agents Phase 2
68 Acetylcholine Release Inhibitors Phase 2
69 Botulinum Toxins Phase 2
70 Botulinum Toxins, Type A Phase 2
71 Dopamine agonists Phase 2
72 Analgesics Phase 2
73 Anti-Anxiety Agents Phase 2
74 Adjuvants, Anesthesia Phase 2
75 Hypnotics and Sedatives Phase 2
76 GABA Modulators Phase 2
77 Excitatory Amino Acid Antagonists Phase 2
78 Anesthetics Phase 2
79 Anesthetics, General Phase 2
80 Anesthetics, Dissociative Phase 2
81 Anesthetics, Intravenous Phase 2
82 Excitatory Amino Acids Phase 2
83 Anti-Inflammatory Agents Phase 2
84 Hydrocortisone-17-butyrate Phase 2
85 Hydrocortisone 17-butyrate 21-propionate Phase 2
86 Hydrocortisone hemisuccinate Phase 2
87 Serotonin Receptor Agonists Phase 2
88 Hormones Phase 2
89 Contraceptives, Oral Phase 2
90 Contraceptives, Postcoital Phase 2
91 glucocorticoids Phase 2
92 Contraceptive Agents Phase 2
93 Luteolytic Agents Phase 2
94 Hormone Antagonists Phase 2
95 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
96 N-monoacetylcystine Phase 2
97 Respiratory System Agents Phase 2
98 Free Radical Scavengers Phase 2
99 Antidotes Phase 2
100 Antioxidants Phase 2
101 Protective Agents Phase 2
102 Expectorants Phase 2
103 Antiviral Agents Phase 2
104 Vitamins Phase 1
105
Guanfacine Approved, Investigational 29110-47-2 3519
106
Methylphenidate Approved, Investigational 113-45-1 4158
107
Valproic acid Approved, Investigational 99-66-1 3121
108
Naloxone Approved, Vet_approved 465-65-6 5284596
109
Buprenorphine Approved, Illicit, Investigational, Vet_approved 52485-79-7 40400 644073
110
Morphine Approved, Investigational 57-27-2 5288826
111
Melatonin Approved, Nutraceutical, Vet_approved 73-31-4 896
112
Inulin Approved, Investigational, Nutraceutical 9005-80-5 24763
113 Antihypertensive Agents
114 Adrenergic alpha-2 Receptor Agonists
115 Adrenergic Agonists
116 Adrenergic alpha-Agonists
117 Adrenergic Agents
118 Central Nervous System Stimulants
119 Dopamine Uptake Inhibitors
120 Contraceptives, Oral, Combined
121 Opiate Alkaloids
122 Buprenorphine, Naloxone Drug Combination
123 Psychotropic Drugs
124 Antipsychotic Agents
125 Vasopressins
126 Arginine Vasopressin
127 Acidophilus

Interventional clinical trials:

(showing 169, show less)
# Name Status NCT ID Phase Drugs
1 Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder: a Randomized, Double Blind Clinical Trial. Unknown status NCT00437099 Phase 4 Omacor®;Placebo
2 Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder Completed NCT00634062 Phase 4 Lamotrigine;Placebo
3 Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder: The UAB Borderline Rating Scale (BRS) Completed NCT00204347 Phase 4 risperidone
4 Treating Suicidal Behavior and Self-Mutilation in Borderline Personality Disorder Completed NCT00533117 Phase 4 Fluoxetine
5 Treating Suicidal Behavior and Self-Mutilation in Borderline Personality Disorder: Predictors of Change Completed NCT00834834 Phase 4 Fluoxetine;Citalopram
6 Treatment of Primary Mood Disorders in the Comorbidly Ill Completed NCT00178061 Phase 4
7 Effect of Probiotics on Central Nervous System Functions in Humans Unknown status NCT02793193 Phase 2, Phase 3 Antibiotic
8 Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Double-Blind Comparison With Placebo Completed NCT00088036 Phase 3 Olanzapine
9 Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Flexible Dose Double-Blind Comparison With Placebo Completed NCT00091650 Phase 3 Olanzapine;placebo
10 BOSCOT: A Randomised Control Trial of Cognitive Behavioural Therapy Plus Treatment as Usual Versus Treatment as Usual in the Treatment of Borderline Personality Disorder Completed NCT00538135 Phase 3
11 A Phase III Randomized Double-blind, 12 Week, Placebo Controlled Trial of Transdermal Selegiline in Borderline Personality Disorder (BPD) to Evaluate Efficacy and Safety Completed NCT01912391 Phase 3 Selegiline;Placebo (for Selegiline)
12 Seroquel XR for the Management of Borderline Personality Disorder (BPD) Completed NCT00880919 Phase 3 quetiapine extended-release;Placebo
13 Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder Completed NCT00122070 Phase 3 Quetiapine Fumarate
14 Short-term Versus Long-term Mentalization-based Therapy for Outpatients With Subthreshold or Diagnosed Borderline Personality Disorder: a Randomized Clinical Trial Recruiting NCT03677037 Phase 3
15 Evaluation of the Efficacy of the Opioid Antagonist Naltrexone on the Incidence and Intensity of Flashbacks and Dissociative States in Patients With Borderline Personality Disorder Terminated NCT00124839 Phase 3 Naltrexone
16 Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence Withdrawn NCT00463775 Phase 3 Topiramate
17 Acetaminophen and Social Pain in Borderline Personality Disorder Unknown status NCT02108990 Phase 2 Acetaminophen
18 The Efficacy of a Cognitive-Behavioural Intervention in Deliberate Self-Harm Patients: A Randomized Controlled Trial Among Adolescents and Young Adults Unknown status NCT00169884 Phase 2
19 Pilot Study of Central Meditation and Imagery Therapy for Borderline Personality Disorder Completed NCT02125942 Phase 1, Phase 2
20 The Effect of Quetiapine on Psychotic-Like Symptoms in Borderline Personality Disordered Patients: A Randomised Placebo-Controlled Trial Completed NCT00254748 Phase 2 Quetiapine fumarate;Placebo
21 Assessment and Treatment of Parasuicidal Patients Completed NCT00183651 Phase 2
22 Ziprasidone in the Treatment of Borderline Personality Disorder: A Double-Blind, Placebo-Controlled, Randomized Study Completed NCT00635921 Phase 2 ziprasidone;Placebo
23 Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder Completed NCT01133301 Phase 2 Naltrexone;Placebo
24 Psychodynamic Therapy for Patients With Borderline Personality Disorder and Alcohol Abuse Completed NCT00145678 Phase 2
25 Treating PTSD in Patients With Borderline Personality Disorder Completed NCT01081314 Phase 1, Phase 2
26 A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Assess the Safety and Efficacy of Citalopram in Combination With Lithium or Placebo in the Treatment of Symptoms in Patients With Depressive Mood Disorders Completed NCT01189812 Phase 2 Lithium Carbonate;Placebo;Citalopram
27 Cognitive Behavioral Therapy for PTSD in Addiction Treatment: A Randomized Pilot Trial Completed NCT01456338 Phase 2
28 Cognitive Therapy for PTSD in Addiction Treatment Completed NCT00685451 Phase 1, Phase 2
29 The Use of Oxytocin as Adjunctive Therapy for the Treatment of Schizophrenia: a Randomized, Double Blind Trial Completed NCT01699997 Phase 2 Oxytocin;Placebo
30 Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD) Recruiting NCT02728778 Phase 2 incobotulinumtoxin A
31 A Double-Blind, Placebo-Controlled Study of Brexpiprazole in the Treatment of Borderline Personality Disorder. Recruiting NCT03418675 Phase 2 Rexulti;Placebo
32 A Randomised Double-blind Placebo Controlled Investigation of the Efficacy of a Novel Drug as an Adjunct in Patients With Borderline Personality Disorder Recruiting NCT02097706 Phase 2 NMDA receptor antagonist (active drug)
33 A Randomized Active Placebo Controlled Trial of Ketamine in Borderline Personality Disorder Recruiting NCT03395314 Phase 2 Ketamine;Midazolam
34 Dialectical Behavior Therapy (DBT) for Adolescents With Bipolar Disorder Recruiting NCT02003690 Phase 2 Pharmacotherapy
35 Investigating the Impact of Oxytocin on Irritability/Emotional Dysregulation in Children and Adolescents With Disruptive Behavior and Mood Disorders, and the Possible Mediating Role of Amygdala Activity Recruiting NCT02824627 Phase 2 Oxytocin;Placebo
36 Multimodal Study of the Emotional Regulation and Impulsivity Among Adolescents With Borderline Personality Disorder : Stress Reactivity and Functional Imaging Not yet recruiting NCT03209102 Phase 2
37 SSRIs and Self-harm in Borderline Personality Disorder Terminated NCT01103180 Phase 2 Escitalopram
38 Preliminary, Double Blind, Placebo Controlled Trial of the Effect of Glucocorticoid Receptor Antagonist Treatment on Biologic and Symptom Outcomes in Patients With Borderline Personality Disorder and Histories of Childhood Abuse Terminated NCT01212588 Phase 2 mifepristone;Placebo
39 A Double-Blind, Placebo-controlled Pilot Study of NAC Addition to Dialectical Behavioral Therapy for the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder Terminated NCT00539188 Phase 2 N-Acetylcysteine;placebo
40 Creativity Group for Borderline Personality Disorder Unknown status NCT01343550 Phase 1
41 Study of Outcome With an Intervention From the Cape Cod Model of Psychotherapy for Subjects in a Behavioral Crisis and With the Diagnosis of Borderline Personality Disorder (BPD) or Post-Traumatic Stress Disorder (PTSD) Unknown status NCT00269139 Phase 1
42 Evaluating the Effectiveness of Dialectical Behaviour Skills Training for Suicidality in Borderline Personality Disorder Completed NCT01193205 Phase 1
43 N-Acetylcysteine in the Treatment of Deliberate Self-Harm in Adolescents: An Open Label Pilot Study Completed NCT01111734 Phase 1 fMRI
44 Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Recruiting NCT02149823 Phase 1 Syntocinon 24 Intranasal Units (IU);Syntocinon 40 Intranasal Units (IU);Intranasal Placebo
45 Effect of Fish Oil vs. Placebo on Subjective Effects of Alcohol in Healthy Humans Recruiting NCT03010917 Phase 1 Fish Oil with ethanol and placebo ethanol infusions;Placebo with ethanol and placebo ethanol infusions
46 Dialectical Behavioral Therapy for Patients With Borderline Personality Disorder Unknown status NCT00252031
47 A Sham-controlled Trial of Effect of High-frequency Transcranial Magnetic Stimulation in the Management of Borderline Personality Disorder Patients Unknown status NCT01602497
48 Event Related Potentials in Borderline Personality Disorder and Major Depression Unknown status NCT01469663
49 Effects of Dialectical Behavioral Therapy and Escitalopram on Impulsive Aggression, Affective Instability and Cognitive Processing in Borderline Personality Disorder Unknown status NCT00255554 Escitalopram
50 Emotional Reaction of Patients With Borderline Personality Disorder (BPD)on Stimuli Connected to Self-injury - A Comparison Between Patients With BPD and a Healthy Control Group. Unknown status NCT03149926
51 Open-label Trial on Therapeutic Effect and Tolerability of Nalmefene in Subjects With Alcohol Use Disorder and Comorbid Borderline Personality Disorder Unknown status NCT02752503 Nalmefene
52 Guanfacine in the Treatment of Borderline Personality Disorder Unknown status NCT00358969 guanfacine (Tenex)
53 Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder Unknown status NCT00131781
54 Promoting Recovery Processes in Women Diagnosed With Borderline Personality Disorder Using a Dynamic Cognitive Intervention Unknown status NCT01531634
55 Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder Unknown status NCT01683136
56 A Double Blind Crossover Study on the Effect of Methylphenidate on Decision-making Ability of Adults With Borderline Personality Disorder (BPD) Compared to Adults With Attention Deficit Hyperactivity Disorder (ADHD) and Healthy Adults Unknown status NCT01426984 methylphenidate
57 Connectivity and Social Cognition in Adolescent Girls With Borderline Personality Disorder, a Pilot Study Unknown status NCT03139825
58 A Randomized Control Trial of Narrative Exposure Therapy Versus Treatment as Usual in the Therapy of Borderline Personality Disorder Unknown status NCT01033708
59 Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder Unknown status NCT00633802 Risperidone
60 A Randomized Controlled Study of the Efficacy of an Intensified, Inpatient Adaptation of Dialectical Behavior Therapy (DBT) for a Population of Borderline Patients (Young Adults/Adults: 18 - 40), Compared With Standard Outpatient DBT. Unknown status NCT01904227
61 Changes in Methylation Status of BDNF Gene After Receiving Dialectical Behavior Therapy in Patients With Borderline Personality Disorder Unknown status NCT02134223
62 Dialectical Behavioral Therapy (DBT) Based Skills Group for Children With Emotional Dysregulation and Their Parents Unknown status NCT01299740
63 Adapting the Systems Training and Emotional Predictability and Problem Solving Group (STEPPS) for Service Users With Complex Needs. A Pilot Evaluation of STEPPS High Intensity (STEPPS HI) Within Forensic Inpatient Services Unknown status NCT02601391
64 Effectiveness of the First French Psychoeducational Program on Unipolar Depression: Study Protocol for a Randomized Controlled Trial. Unknown status NCT02501226
65 Emotional and Non-emotional Regulation in Patients With Emotional Instability Personality Disorder (EIP) and Attention Deficit Hyperactivity Disorder (ADHD) Symptoms Unknown status NCT02797873
66 The Interest of a Specific Combined Treatment (Psychotherapy and Pharmacotherapy) in Patients With Dissociative Disorders Unknown status NCT00630981 Pharmacological treatment (Quetiapine and/or Escitalopram)
67 A Double-Blind and Placebo Controlled Assessment of Depakote ER in Borderline Personality Disorder Completed NCT00222482 Depakote ER
68 Assessment of Longitudinal Functional Magnetic Resonance Imaging (fMRI) as a Brain Measure for Impulsivity in a Borderline Personality Disorder (BPD) Model Completed NCT02755181
69 Emotion Regulation Group Therapy (ERGT) for Women Engaging in Non-suicidal Self-Injury (NSSI) - an Effectiveness Study Completed NCT01986257
70 Effectiveness of Group Based Schema Therapy in the Treatment of Borderline Personality Disorder and Avoidant Personality Disorder Completed NCT00247234
71 A Randomized-Controlled Trial of Transference-Focused Psychotherapy vs. Treatment by Experienced Community Psychotherapists for Borderline Personality Disorder Completed NCT00714311
72 Effectiveness of Therapeutic Treatment: Hot and Cold Self-regulation in Posttraumatic Stress Disorder, Dissociative Disorder, and Borderline Personality Disorder Completed NCT02459340
73 Parenting Skills for Mothers With Borderline Personality Disorder: A Newly Developed Group Training Program Completed NCT02935218
74 Effects of Transcranial Direct Current Stimulation on the Cognitive Control of Negative Stimuli in Borderline Personality Disorder Completed NCT03636139
75 Symptom, Alexithymia and Self-image Outcomes of Mentalization-Based Treatment for Borderline Personality Disorder: a Naturalistic Study Completed NCT03295838
76 "Brain Correlates Of Affect Regulation In BPD" Completed NCT00275288
77 Effects of Motive-Oriented Therapeutic Relationship in the Early-Phase Treatment of Borderline Personality Disorder Completed NCT01896024
78 Randomized, Active-controlled, Clinical Trial Comparing Effects of Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder Completed NCT02397031
79 Efficacy of Dialectical Behavior Therapy in Patient With Self Harming Behavior and Traits Within the Spectrum of Borderline Personality Disorder. Completed NCT01512602
80 Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Borderline Personality Disorder (BPD) Completed NCT01076933
81 Circadian Sleep-wake Cycles, Well-being and Light Therapy in Borderline Personality Disorder Completed NCT01311193
82 Effectiveness of a 24 Hour Phone Line on the Rate of Suicide Attempts in Borderline Patients Completed NCT00603421
83 Impact of Therapist Change After Initial Contact and Traumatic Burden on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving Dialectical Behavior Therapy Completed NCT03018639
84 Use of Care Services by Patients With Borderline Personality Disorder Completed NCT02829658
85 Brain Correlates of Olanzapine Treatment Response in BPD Completed NCT00275301 olanzapine
86 Why Does Cortisol Enhance Memory Retrieval in Patients With Borderline Personality Disorder and Posttraumatic Stress Disorder? Investigating the Neuronal Correlates of Cortisol Administration and the Effects of Stress Exposure Completed NCT02523664 Hydrocortisone;Placebo
87 Repetitive Transcranial Magnetic Stimulation in Borderline Personality Disorder Patients. Effects in Clinical Measurements, Inhibition, Cognitive Flexibility, and Social Cognition Process Completed NCT02273674
88 Staff Nurse Perceptions of the Impact of Mentalization Based Treatment (MBT) Skills Training on Clinical Practice When Working With Borderline Personality Disorder (BPD) in Acute Mental Health Admission Wards: A Qualitative Analysis. Completed NCT02239055
89 Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder: a Controlled Trial in Taiwan Completed NCT01952405
90 A Cognitive Group Treatment for Borderline Outpatients Completed NCT00055315
91 Evaluating the Effectiveness of 'The Endeavour Programme': DBT for Irish Adults With Borderline Personality Disorder Completed NCT03166579
92 Effect on Relationship of a Brief Preventive Program: Pragmatic Pilot Randomized Controlled Trial." - Supportive Program for Mother With BPD Completed NCT02203708
93 Evaluation of Dialectical Behavior Therapy (DBT) Completed NCT00117741
94 Training of Neural Responding With fMRI Neurofeedback in Borderline Personality Disorder Completed NCT02866110
95 Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study Completed NCT02988037
96 Effectiveness of the Iconic Therapy in Youth With Suicidal Ideation/Self-injuring Behavior and Borderline Personality Traits: Study Protocol for a Randomized Controlled Trial Completed NCT03011190
97 A Study on the Effects of a Personality Disorder Day Hospital Program on Clients Body Mass Index Completed NCT00202215
98 Calling for Care: Cell Phones for Mood Telemetry Completed NCT01083823
99 Evaluation of a Modified Dialectical Behavior Therapy Program for Borderline Personality Disorder Completed NCT01635556
100 Brief Admission Skane: Can Brief Admission Replace General Admission for Individuals With Self-harm and Acute Risk of Suicide Completed NCT02985047
101 Evaluation of a Coordinated National Implementation of DBT in Community Mental Health Services in Ireland Completed NCT03180541
102 Sequential Brief Adlerian Psychodynamic Psychotherapy in Heavy Users of a Mental Health Service With Borderline Personality Disorder: a Two Years Follow-up Preliminary Randomized Study. Completed NCT01356069
103 Randomized Controlled Trial Comparing the Effects on Psychosocial Functioning of Cognitive Rehabilitation Versus Psychoeducation in Borderline Personality Disorder Completed NCT02033044
104 Effects of Mindfulness Training on Emotion Regulation and Impulsivity Completed NCT03363230
105 An fMRI Study of the Enhancement of Emotion Regulation in Borderline Patients Completed NCT02465697
106 Survey of the Consultation Service of the Providence Continuing Care Centre Personality Disorder Service Users Satisfaction With the Change in Service Delivery Completed NCT00202202
107 Group Dialectical Behavioural Therapy for Mood Instability Within Bipolar Disorder: An Open Trial Completed NCT02637401
108 Treatment of Aggression, Anger and Emotional Dysregulation in Borderline Personality Disorder Completed NCT00467038
109 Pilot Study Examining the Impact of a Cognitive Processing Therapy (CPT) Group for Patients With Co-Occurring Borderline Personality Disorder and Posttraumatic Stress Disorder Completed NCT02574429
110 Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder Completed NCT02129790
111 A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings Completed NCT03035110
112 Psychoeducation of Borderline Patients Completed NCT01719731
113 Randomized Controlled Trial of Peer to Peer Support for People With Severe Mental Disorders: Schizophrenia, Affective Disorders and Personality Disorders in Comparison to Standard Care Completed NCT02276469
114 Evaluation of Dialectical Behavior Therapy in Treatment of Opioid Addiction and Emotional Problems Completed NCT00218595
115 Dialectical Behavior Therapy (DBT) for Post-Bariatric Patients Experiencing Weight Regain Completed NCT01453517
116 Canadian Institutes of Health Research (CIHR) Team in Innovations in Child and Youth Concurrent Disorders: Service Delivery and Treatment Subproject Completed NCT02243761
117 Treatment of Suicidal and Self-Injurious Adolescents With Emotional Dysregulation Completed NCT01528020
118 Commitment and Motivation in a Brief DBT Intervention for Self Harm Completed NCT02354183
119 Effects of Structured Skills Training Group in Treatment of ADHD in Adults: a Controlled Multicentre Study Completed NCT02685254
120 Examining the Effectiveness of Self-Acceptance Group Therapy Completed NCT02121561
121 Understanding Daily Fluctuations in Self-Regulation Completed NCT03006653
122 A Mindfulness-Based Intervention for Youth With Concurrent Disorders Completed NCT00244699
123 High Risk Suicidal Behavior in Veterans - Assessment of Predictors and Efficacy of Dialectical Behavior Therapy Completed NCT02462694
124 Evaluating a Novel Method of Generalizing Emotion Regulation Completed NCT01653548
125 Pilot Study of Prevention of Alcohol and Other Drug Use Using Motivational Interviewing Among Youth in Ukraine Completed NCT02347644
126 Feasibility and Acceptability of Medical Skin Camouflage for Recovery of Women With Self-Harm Scarring in Prison Completed NCT02638974
127 "The Effects of Oxytocin on Patients With Borderline Personality Disorder" Recruiting NCT01243658 Oxytocin
128 Dialectical Behavior Therapy for Adolescents at Rutgers University Recruiting NCT03861858
129 Effect of Transcranial Magnetic Stimulation on Dorsomedial Cortex in Clinical and Neuropsychological Variables in Borderline Personality Disorder Recruiting NCT03832777
130 The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults: A Pilot Behavioral Study Recruiting NCT02225600 40 IU Intranasal Oxytocin;Placebo;24 IU intranasal Oxytocin
131 Change in Mindfulness in Borderline Personality Disorder After Dialectic-behavioural Therapy (DBT): A Pre-post-comparison Recruiting NCT03297840
132 Mechanisms of Change in Brief Treatment for Borderline Personality Disorder: A Randomized Controlled Trial Recruiting NCT03717818
133 Dialectical Behavior Therapy Rutgers University Research Program Recruiting NCT03123198
134 Magnetic Seizure Therapy for the Treatment of Treatment-Resistant Depression and Suicidal Ideation in Borderline Personality Disorder Recruiting NCT03361826
135 Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder Recruiting NCT03060902
136 Research Evaluating the EffectiVeness of Adding an Internet-Based Self-Management Intervention to Usual Care in the Treatment of Borderline Personality Disorder - REVISIT BPD Recruiting NCT03418142
137 Exploration of Theory of Mind in a Situation of Social Rejection in Borderline Personality Disorder Recruiting NCT03968081
138 Dialectic Behavior Treatment Skills System (DBT-SS) as Treatment for Cognitively Challenged Individuals With Deliberate Self-harm Recruiting NCT03627663
139 An 18-Month Psychotherapy of Borderline Personality Disorder Recruiting NCT03329677
140 Prediction and Outcome Study in PTSD and (Borderline) Personality Disorders Recruiting NCT03833453
141 Mentalization-based Training for Adolescents With Conduct Disorder (MBT-CD): A Randomized Controlled Trial Recruiting NCT02988453
142 Proof-of-concept and Validity of Amygdala-neurofeedback in Adolescent Patients With Emotion Dysregulation Recruiting NCT03964545
143 A Transdiagnostic Group Intervention to Enhance Distress Tolerance: A Mixed Methods Pilot Evaluation in an Acute Inpatient Setting Recruiting NCT03712332
144 Pilot Study of Cognitive Behavioral Therapy-Informed Physical Therapy Intervention in Functional Neurological Disorders Recruiting NCT03731078
145 Emotional Dysregulation in Para-suicidal Behavior: Effects of Dialectical Behavioral Therapy on Emotional Processing, a Triangulation Approach Recruiting NCT03846375
146 Efficacy Of Repetitive Transcranial Magnetic Stimulation In The Treatment Of Refractory Depression Among Patients With Borderline Personality Disorder Active, not recruiting NCT03472638
147 Mentalization-Based Treatment in Groups for Adolescents With Borderline Personality Disorder (BPD) or Subthreshold BPD Versus Treatment As Usual - the M-GAB Randomized Controlled Trial Active, not recruiting NCT02068326
148 A Randomized Controlled Clinical Trial (RCCT) to Test the Effectiveness of Narrative Exposure Therapy (NET) Versus Dialectical-Behavioral Therapy in Reducing Trauma Related Symptoms in Women Suffering From Borderline Personality Disorder (BPD) and Posttraumatic Stress Disorder (PTSD) Active, not recruiting NCT02517723
149 Dialectical Behaviour Therapy for Chronically Self-harming Individuals With BPD: Evaluating the Clinical and Cost Effectiveness of a 6-month Treatment Active, not recruiting NCT02387736
150 Isolating Mechanisms in the Treatment of Borderline Personality Disorder Active, not recruiting NCT03408860
151 Neuroimaging and Clinical Markers of Change in Borderline Personality Disorder After Metacognitive Interpersonal Therapy - Standard Approach Active, not recruiting NCT02370316
152 Process-Outcome Study on Psychotherapeutic Interventions in Adolescents With Personality Disorders Active, not recruiting NCT02518906
153 Long Term Efficacy of Dialectical Behaviour Therapy vs Enhanced Usual Care for Adolescents With Self-Harming and Suicidal Behaviours Active, not recruiting NCT01593202
154 The mDIARY Study: Using Smartphones for Daily Selfmonitoring of Skilluse and Outcome in Dialectical Behavior Therapy With Borderline Personality Disorder: A Combined RCT and Timeseries Study Enrolling by invitation NCT03191565
155 Latent Toxoplasmosis in Females With Borderline Personality Disorder - Occurrence, Clinical Features, and Impact on Effectiveness of Combined Pharmacotherapeutic and Psychotherapeutic Treatment Not yet recruiting NCT03932656 Psychopharmaceuticals
156 Mentalization Based Treatment - Introductory Group for Male Prisoners With Borderline and/or Antisocial Personality Disorder in Her Majesty's Prison Barlinnie Not yet recruiting NCT04033835
157 Effet de la tDCS Sur l'impulsivité Chez Les Personnes Souffrant d'un Trouble Borderline : TIMBER Not yet recruiting NCT03498937
158 Study of Prevalence and Characteristics of Hallucinations in Patients With Borderline Personality Disorder Not yet recruiting NCT03519035
159 Study of Shame Propensity as a Prognostic Factor of Suicidal Behaviors in Patients With Borderline Personality Disorder Not yet recruiting NCT03994510
160 Efficacy of a Dialectical Behavior Therapy and Acceptance Commitment Therapy Short Program for Prevention of Suicidal Behavior in Patients With Borderline Personality Disorder Not yet recruiting NCT03880071
161 Reactivity of Patients With Borderline Personality Disorder to an Ecological Interpersonal Stress : Pathophysiology of Suicidal Behaviors Study Model Not yet recruiting NCT03602521
162 Randomized Controlled Study on the Efficacy of the NECT Program (Cognitive Therapy and Narrative Development) on Improving Social Functioning in People With Severe Psychic Disorders Not yet recruiting NCT03972735
163 Randomized Placebo-controlled Treatment of Impulsivity in Adults With Probiotics Not yet recruiting NCT03495375
164 Dialectical Behavioral Therapy in High Risk OrthopaedicTrauma Patients Not yet recruiting NCT03776929
165 Effectiveness of the First French Psychoeducational Program for Suicidal Behavior : a Randomized Controlled Trial Not yet recruiting NCT03185026
166 English Title: Extreme Challenges - Psychopathology, Treatment Organization and Experiences Among Psychiatric Inpatients With Severe Self-harming Behavior in Norway Not yet recruiting NCT03768674
167 Neuropsychiatric Mechanisms of Change in Mentalization Based Treatment of Borderline Personality Disorder (MENTAB) Terminated NCT01720953
168 Mindfulness Approach for Adults Experiencing Borderline Personality Disorder; Supporting the Management of Intense and Fluctuating Emotions, a Feasibility Study Withdrawn NCT02849431
169 College Students Who Self-Harm: An Intervention Study Withdrawn NCT02522143

Search NIH Clinical Center for Borderline Personality Disorder

Cochrane evidence based reviews: borderline personality disorder

Genetic Tests for Borderline Personality Disorder

Anatomical Context for Borderline Personality Disorder

MalaCards organs/tissues related to Borderline Personality Disorder:

41
Brain, Testes, Amygdala, Cortex, Skin, Pituitary, Eye

Publications for Borderline Personality Disorder

Articles related to Borderline Personality Disorder:

(showing 5886, show less)
# Title Authors PMID Year
1
Association analysis between gene variants of the tyrosine hydroxylase and the serotonin transporter in borderline personality disorder. 9 38
20146650 2010
2
In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders. 9 38
19523495 2009
3
Interaction between gene variants of the serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT) in borderline personality disorder. 9 38
18756498 2009
4
Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder. 9 38
17597424 2007
5
Association between the serotonin transporter gene and personality traits in borderline personality disorder patients evaluated with Zuckerman-Zuhlman Personality Questionnaire (ZKPQ). 9 38
18004675 2007
6
Monoamine oxidase a gene is associated with borderline personality disorder. 9 38
17417058 2007
7
[Personality disorders in a nonclinical sample of adolescents]. 9 38
12506264 2002
8
Out of control? Acting out anger is associated with deficient prefrontal emotional action control in male patients with borderline personality disorder. 38
30553826 2019
9
Personality disorders and physical comorbidities: a complex relationship. 38
31219842 2019
10
DSM Borderline Criterion Function Across Age-Groups: A Cross-Sectional Mixed-Method Study. 38
30003799 2019
11
Violent offending in borderline personality disorder and attention deficit/hyperactivity disorder. 38
30844407 2019
12
The link between rejection sensitivity and borderline personality disorder: A systematic review and meta-analysis. 38
30900278 2019
13
Evaluating "mentalizing positive affect" as an intervention for enhancing positive affectivity in borderline personality disorder using a single-case multiple-baseline design. 38
31393151 2019
14
Heart rate variability during a cognitive reappraisal task in female patients with borderline personality disorder: the role of comorbid posttraumatic stress disorder and dissociation. 38
30198447 2019
15
Stigma, Emotion Appraisal, and the Family Environment as Predictors of Carer Burden for Relatives of Individuals Who Meet the Diagnostic Criteria for Borderline Personality Disorder. 38
30307828 2019
16
The experiences of people with borderline personality disorder admitted to acute psychiatric inpatient wards: a meta-synthesis. 38
28686468 2019
17
Ruminative responses to interpersonal precipitants mediate borderline personality disorder features' effects on distress reactivity and recovery in daily life. 38
31392728 2019
18
Resting-state functional connectivity after hydrocortisone administration in patients with post-traumatic stress disorder and borderline personality disorder. 38
31262544 2019
19
Individualized treatment response prediction of dialectical behavior therapy for borderline personality disorder using multimodal magnetic resonance imaging. 38
31414575 2019
20
Relations among maternal withdrawal in infancy, borderline features, suicidality/self-injury, and adult hippocampal volume: A 30-year longitudinal study. 38
31381974 2019
21
Parent Emotion Socialization and Child Emotional Vulnerability as Predictors of Borderline Personality Features. 38
31388862 2019
22
Barriers and facilitators to the implementation of a stepped care intervention for personality disorder in mental health services. 38
31411004 2019
23
Homicidal Ideation and Forensic Psychopathology: Evidence From the 2016 Nationwide Emergency Department Sample (NEDS). 38
31404481 2019
24
Does an adapted Dialectical Behaviour Therapy skills training programme result in positive outcomes for participants with a dual diagnosis? A mixed methods study. 38
31412957 2019
25
Suicide ideation and attempts in obsessive-compulsive disorder. 38
31046037 2019
26
Cognitive and Behavioral Differentiation of Those With Borderline Personality Disorder and Bipolar Disorder. 38
31283725 2019
27
Circadian rest-activity patterns in bipolar disorder and borderline personality disorder. 38
31431612 2019
28
Screening for Bipolar Disorder and Finding Borderline Personality Disorder: A Replication and Extension. 38
30036171 2019
29
The 24-year course of major depression in patients with borderline personality disorder and personality-disordered comparison subjects. 38
31400625 2019
30
Construct Validity of the McLean Screening Instrument for Borderline Personality Disorder in Two Singaporean Samples. 38
29949444 2019
31
A meta-analysis of treatment as usual for borderline personality disorder. 38
31414854 2019
32
Cross-Domain Assessment of Distress Intolerance: Associations With Borderline Personality Disorder Features. 38
30307823 2019
33
Respiratory Sinus Arrhythmia Mediates Links Between Borderline Personality Disorder Symptoms and Both Aggressive and Violent Behavior. 38
30307825 2019
34
Staff and client perspectives of the Open Borders programme for people with borderline personality disorder. 38
31081282 2019
35
Neurophysiological activity following rewards and losses among female adolescents and young adults with borderline personality disorder. 38
31318241 2019
36
Neurocircuitry associated with symptom dimensions at baseline and with change in borderline personality disorder. 38
31302291 2019
37
Predictors of short- and long-term recurrence of suicidal behavior in borderline personality disorder. 38
31155713 2019
38
A short screening tool for borderline personality disorder (Short-Bord): Validated by Rasch analysis. 38
31415930 2019
39
Are self-report cognitive empathy ratings valid proxies for cognitive empathy ability? Negligible meta-analytic relations with behavioral task performance. 38
31120296 2019
40
Borderline personality disorder and emotion dysregulation. 38
31169118 2019
41
Toward an animal model of borderline personality disorder. 38
31201478 2019
42
Whole-brain functional connectivity during script-driven aggression in borderline personality disorder. 38
30885789 2019
43
Changes in facial emotion expression during a psychotherapeutic intervention for patients with borderline personality disorder. 38
31071663 2019
44
[Erratum to: Oxytocin and maltreatment potential : Influence of maternal depression, borderline personality disorder and experience of early childhood maltreatment]. 38
31089782 2019
45
Precursors of the emotional cascade model of borderline personality disorder: The role of neuroticism, childhood emotional vulnerability, and parental invalidation. 38
30896201 2019
46
Borderline personality disorder and its association with bipolar spectrum and binge eating disorder in college students from South India. 38
31302438 2019
47
Mixed-methods evaluation of an educational intervention to change mental health nurses' attitudes to people diagnosed with borderline personality disorder. 38
30830704 2019
48
Associations of positive and negative emotions with ego-resiliency and quality of life in borderline personality disorder: A daily diary study. 38
31318235 2019
49
Impulse control under emotion processing: an fMRI investigation in borderline personality disorder compared to non-patients and cluster-C personality disorder patients. 38
31321661 2019
50
The weirdness of having a bunch of other minds like yours in the room: The lived experiences of mentalization-based therapy for borderline personality disorder. 38
31301159 2019
51
Effects of hydrocortisone on autobiographical memory retrieval in patients with posttraumatic stress disorder and borderline personality disorder: the role of childhood trauma. 38
31279324 2019
52
Differentiating symptom profiles of ICD-11 PTSD, complex PTSD, and borderline personality disorder: A latent class analysis in a multiply traumatized sample. 38
31259603 2019
53
A study of risky sexual behavior, beliefs about sexual behavior, and sexual self-efficacy in adolescent inpatients with and without borderline personality disorder. 38
31259605 2019
54
Trust and Rejection Sensitivity in Personality Disorders. 38
31264030 2019
55
Borderline Symptoms at Age 12 Signal Risk for Poor Outcomes During the Transition to Adulthood: Findings From a Genetically Sensitive Longitudinal Cohort Study. 38
31325594 2019
56
Convergent and Discriminant Validity of Self-Report and Performance-Based Assessment of Object Relations. 38
31305156 2019
57
Comparing DSM-5-Hybrid, SWAP, and PDM prototype models of personality disorders: Convergent and divergent findings. 38
31033327 2019
58
Description and prediction of social isolation in borderline patients over 20 years of prospective follow-up. 38
31045388 2019
59
Online sexual solicitation in adolescents; socio-demographic risk factors and association with psychiatric disorders, especially posttraumatic stress disorder. 38
31306899 2019
60
Correlates between Five-Factor Model traits and the Revised Diagnostic Interview for Borderlines dimensions in an adolescent clinical sample. 38
31287247 2019
61
Effects of brief daily mindfulness practice on affective outcomes and correlates in a high BPD trait sample. 38
31408773 2019
62
Familial factors and the risk of borderline personality pathology: genetic and environmental transmission. 38
31317840 2019
63
Does Behavioural Activation Lack Credibility Among Those Who Need It Most? A Comparison of Responses to Rationales for Behavioural Activation and Schema Therapy. 38
30636651 2019
64
Predictors of improvement in an open-trial multisite evaluation of emotion regulation group therapy. 38
30230412 2019
65
Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis. 38
31227264 2019
66
The Limits between Bipolar Disorder and Borderline Personality Disorder: A Review of the Evidence. 38
31284435 2019
67
Mineralocorticoid receptor function and cognition in health and disease. 38
30243757 2019
68
Relationship Between Impulsivity and Clinical and Sociodemographic Variables Among Lebanese Patients With Bipolar Disorder: Results of a Cross-Sectional Study. 38
31192793 2019
69
Borderline Personality Features in Inpatients with Bipolar Disorder: Impact on Course and Machine Learning Model Use to Predict Rapid Readmission. 38
31291208 2019
70
Common and distinct patterns of grey matter alterations in borderline personality disorder and bipolar disorder: voxel-based meta-analysis. 38
30846010 2019
71
Borderline Personality and Bipolar Disorders Cannot Be Differentiated Electrophysiologically. 38
31282204 2019
72
Exploring schizophrenia spectrum psychopathology in borderline personality disorder. 38
31289925 2019
73
Symptoms of anorexia nervosa and bulimia nervosa have differential relationships to borderline personality disorder symptoms. 38
31305226 2019
74
Longitudinal associations among primary and secondary psychopathic traits, anxiety, and borderline personality disorder features across adolescence. 38
30628800 2019
75
Influence of betrayal trauma on borderline personality disorder traits. 38
30681038 2019
76
Borderline personality disorder and ICD-11: A chance for change. 38
30897927 2019
77
Psychotic symptoms in adolescents with borderline personality disorder features. 38
30511234 2019
78
Borderline personality disorder and auditory verbal hallucinations. 38
31304765 2019
79
Use your words: The role of emotion labeling in regulating emotion in borderline personality disorder. 38
31374483 2019
80
Optimizing borderline personality disorder treatment by incorporating significant others: A review and synthesis. 38
30714800 2019
81
Inpatient adolescents with borderline personality disorder features: Identity diffusion and narrative incoherence. 38
31033329 2019
82
Managing borderline personality disorder from a life course perspective: Clinical staging and health management. 38
31144839 2019
83
A Meta-analysis and Systematic Review of Emotion-Regulation Strategies in Borderline Personality Disorder. 38
31219881 2019
84
Cognitive heuristics in borderline personality disorder across treatment: A longitudinal non-parametric analysis. 38
30887510 2019
85
Similarities between borderline personality disorder and post traumatic stress disorder: Evidence from resting-state meta-analysis. 38
31369796 2019
86
Borderline personality disorder traits and affect reactivity to positive affect induction followed by a stressor. 38
31299335 2019
87
Borderline personality disorder and eating disorders: a trans-diagnostic approach to unravelling diagnostic complexity. 38
31154810 2019
88
Patients with borderline personality disorder show increased agency in life stories after 12 months of psychotherapy. 38
30113186 2019
89
Group psychotherapy for borderline personality disorder: A meta-analysis of randomized-controlled trials. 38
30869973 2019
90
Why go to the emergency department? Perspectives from persons with borderline personality disorder. 38
30779279 2019
91
Clinical efficacy of a combined acceptance and commitment therapy, dialectical behavioural therapy, and functional analytic psychotherapy intervention in patients with borderline personality disorder. 38
31246370 2019
92
The glutamate to γ-aminobutyric acid ratio in the posterior insula is associated with pain perception in healthy women but not in women with borderline personality disorder. 38
31339871 2019
93
Efficacy of transcranial direct current stimulation in reducing impulsivity in borderline personality disorder (TIMBER): study protocol of a randomized controlled clinical trial. 38
31182143 2019
94
Does a history of childhood abuse moderate the association between symptoms of posttraumatic stress disorder and borderline personality disorder in survivors of intimate partner violence? 38
30742703 2019
95
Low Vocational Outcome Among People Diagnosed With Borderline Personality Disorder During First Admission to Mental Health Services in Denmark: A Nationwide 9-Year Register-Based Study. 38
29505387 2019
96
Changes in mindfulness facets in a dialectical behaviour therapy skills training group program for borderline personality disorder. 38
30672590 2019
97
Negative affect moderates the effect of social rejection on frontal and anterior cingulate cortex activation in borderline personality disorder. 38
31165440 2019
98
Effects of a Painful Stimulus on Stress Regulation in Male Patients With Borderline Personality Disorder: A Pilot Study. 38
30036168 2019
99
The effectiveness of individual schema therapy in older adults with borderline personality disorder: Protocol of a multiple-baseline study. 38
30775612 2019
100
Asenapine: Pharmacological Aspects and Role in Psychiatric Disorders. 38
31291219 2019
101
Experiences of (young) women after out of home placement: An examination of personality disorder symptoms through the lens of child maltreatment. 38
30974255 2019
102
A Recurrent Question: What Is Borderline? 38
29469662 2019
103
My first client: The lioness. 38
31180713 2019
104
Effect of Brief Admission to Hospital by Self-referral for Individuals Who Self-harm and Are at Risk of Suicide: A Randomized Clinical Trial. 38
31173128 2019
105
The subjective-agentic personality sector (SAPS): Introduction to the special issue on self, identity, and psychopathology. 38
31206666 2019
106
Experiential avoidance in adolescents with borderline personality disorder: comparison with a non-BPD psychiatric group and healthy controls. 38
31185829 2019
107
A systematic review and meta-analysis of the Unified Protocol as a transdiagnostic emotion regulation based intervention. 38
31271848 2019
108
Comparing physical and mental health literacy. 38
29701499 2019
109
Mortality and Medical Comorbidity in the Severely Mentally Ill. 38
31366432 2019
110
Psychiatric disorders among offspring of patients with Bipolar and Borderline Personality Disorder. 38
31268172 2019
111
Measurement and mental health disparities: Psychopathology classification and identity assessment. 38
31219231 2019
112
Relationships between recurrence and polarity in major depressive disorders: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts. 38
31195243 2019
113
Borderline personality disorder and self-directed violence in a sample of suicidal army soldiers. 38
31180691 2019
114
Familial risk and heritability of diagnosed borderline personality disorder: a register study of the Swedish population. 38
31160693 2019
115
A Tribute to John G. Gunderson: A Pioneer in Promoting Borderline Personality Disorder Research and Treatment. 38
31161970 2019
116
Affective interference in borderline personality disorder: The lethality of suicidal behavior predicts functional brain profiles. 38
30991253 2019
117
Nursing care for people with borderline personality disorder in the Freirean perspective. 38
31188985 2019
118
Sexuality and sexual health among female youth with borderline personality disorder pathology. 38
29076247 2019
119
Isolating the effect of opposite action in borderline personality disorder: A laboratory-based alternating treatment design. 38
30366576 2019
120
Borderline personality disorder in patients with medical illness: A review of assessment, prevalence, and treatment options. 38
31232916 2019
121
Too Much Too Soon?: Borderline Personality Disorder Symptoms and Romantic Relationships in Adolescent Girls. 38
31240430 2019
122
Deficient Amygdala Habituation to Threatening Stimuli in Borderline Personality Disorder Relates to Adverse Childhood Experiences. 38
31366446 2019
123
Borderline personality disorder: an update for neurologists. 38
31249066 2019
124
Personal and parents' life stories in patients with borderline personality disorder. 38
30809831 2019
125
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial. 38
31234864 2019
126
A Life Span Perspective on Borderline Personality Disorder. 38
31161404 2019
127
Palliative Care for Terminally Ill Individuals With Borderline Personality Disorder. 38
31188458 2019
128
Borderline personality disorder: from understanding ontological addiction to psychotherapeutic revolution. 38
31165236 2019
129
Hallucinations in patients with borderline personality disorder: characteristics, severity, and relationship with schizotypy and loneliness. 38
30712290 2019
130
Borderline personality disorder, complex trauma, and problems with self and identity: A social-communicative approach. 38
31066053 2019
131
Whole-brain microstructural white matter alterations in borderline personality disorder patients. 38
30989833 2019
132
Emotional experiences of clients with borderline personality disorder in dialectical behavior therapy: An empirical investigation of in-session affect. 38
31144840 2019
133
Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines. 38
31140337 2019
134
Development and validation of an emotional picture set of self-injury (EPSI) for borderline personality disorder: protocol for a validation study. 38
31122985 2019
135
Mental health services, care provision, and professional support for people diagnosed with borderline personality disorder: systematic review of service-user, family, and carer perspectives. 38
31099717 2019
136
"The Father of BPD" John G. Gunderson, 1942-2019. 38
31029199 2019
137
"I couldn't change the past; the answer wasn't there": A case study on the subjective construction of psychotherapeutic change of a patient with a Borderline Personality Disorder diagnosis and her therapist. 38
28774224 2019
138
Outcomes for 18 to 25-year-olds with borderline personality disorder in a dedicated young adult only DBT programme compared to a general adult DBT programme for all ages 18. 38
31044536 2019
139
The complexities of the borderline patient: how much more complex when considering physical health? 38
31070464 2019
140
The Development of the ICD-11 Classification of Personality Disorders: An Amalgam of Science, Pragmatism, and Politics. 38
30601688 2019
141
Paranoia and risk of personality disorder in the general population. 38
30989831 2019
142
Complex depression: The treatment of major depression and severe personality pathology. 38
30773631 2019
143
Psychometric properties of the Spanish version of the involvement evaluation questionnaire in caregivers of patients with borderline personality disorders. 38
30747490 2019
144
Evaluation of Reliability and Validity of Chinese-Version Borderline Personality Features Scale for Children. 38
31076565 2019
145
Difficulties regulating emotions mediates the associations of parental psychological control and emotion invalidation with borderline personality features. 38
30520650 2019
146
Disrupted emotional neural circuitry in adolescents with borderline personality traits. 38
30796963 2019
147
A preliminary service evaluation of a personality disorder case management service. 38
30806042 2019
148
Handling suicidal crises in psychodynamic psychotherapy: A process case study. 38
30817004 2019
149
Non-suicidal self-injury and electroconvulsive therapy: Outcomes in adolescent and young adult populations. 38
30844603 2019
150
Psychopathological and psychiatric evaluation of patients affected by lipodystrophy. 38
31144218 2019
151
Alterations of empathy in mothers with a history of early life maltreatment, depression, and borderline personality disorder and their effects on child psychopathology. 38
31115280 2019
152
Screening for depression with the Edinburgh Postnatal Depression Scale and finding borderline personality disorder. 38
30309241 2019
153
[Mental disorders and diabetes mellitus (Update 2019)]. 38
30980168 2019
154
Reduced mentalizing in patients with bulimia nervosa and features of borderline personality disorder: A case-control study. 38
31060534 2019
155
Understanding the genetics and epigenetics of bulimia nervosa/bulimia spectrum disorder and comorbid borderline personality disorder (BN/BSD-BPD): a systematic review. 38
31119586 2019
156
Inpatient Treatment for Patients With Borderline Personality Disorder. 38
31083028 2019
157
Short communication: Diffusion tensor anisotropy in the cingulate in borderline and schizotypal personality disorder. 38
31101379 2019
158
EEG-vigilance regulation in Borderline Personality Disorder. 38
30796933 2019
159
Suicidality in Borderline Personality Disorder. 38
31142033 2019
160
Effects of mindfulness training on the default mode network in borderline personality disorder. 38
31132302 2019
161
Impact of infant crying on mothers with a diagnosis of borderline personality disorder: A qualitative study. 38
30964954 2019
162
The role of attachment characteristics in dialectical behavior therapy for patients with borderline personality disorder. 38
30667573 2019
163
Early maladaptive schemas and borderline personality disorder features in a nonclinical sample: A network analysis. 38
30771229 2019
164
Effectiveness of a 5-Week Inpatient Dialectical Behavior Therapy for Borderline Personality Disorder. 38
31083031 2019
165
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents. 38
31089814 2019
166
Treatment of Borderline Personality Disorder: Is Supply Adequate to Meet Public Health Needs? 38
31138059 2019
167
Altered Oscillatory Responses to Feedback in Borderline Personality Disorder are Linked to Symptom Severity. 38
30689144 2019
168
Differential perception of sharp pain in patients with borderline personality disorder. 38
31034113 2019
169
[Mentalization based treatment (MBT) for borderline personality disorder among a population of French-speaking patients]. 38
29960681 2019
170
Neural Signatures of Social Inclusion in Borderline Personality Disorder Versus Non-suicidal Self-injury. 38
31011853 2019
171
Mentalization in Adolescents With Borderline Personality Disorder: A Comparison With Healthy Controls. 38
29469664 2019
172
A Randomized Controlled Trial of Group Psychoeducation for Carers of Persons With Borderline Personality Disorder. 38
29505385 2019
173
Borderline Personality Disorder: Associations Between Dimensional Personality Profiles and Self-Destructive Behaviors. 38
29505390 2019
174
Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial. 38
30953536 2019
175
Borderline personality disorder is associated with an increased risk of sexually transmitted infections: A nationwide population-based cohort study in Taiwan. 38
30981998 2019
176
Childhood trauma affects processing of social interactions in borderline personality disorder: An event-related potential study investigating empathy for pain. 38
28532273 2019
177
Relationships between the frequency and severity of non-suicidal self-injury and suicide attempts in youth with borderline personality disorder. 38
28718985 2019
178
Nonacceptance of negative emotions in women with borderline personality disorder: association with neuroactivity of the dorsal striatum 38
30964611 2019
179
Perceived Invalidation in Adolescent Borderline Personality Disorder: An Investigation of Parallel Reports of Caregiver Responses to Negative Emotions. 38
30069665 2019
180
Systematic review and meta-analysis of basal cortisol levels in Borderline Personality Disorder compared to non-psychiatric controls. 38
30557762 2019
181
The dissociative subtype of PTSD in women with substance use disorders: Exploring symptom and exposure profiles. 38
30797397 2019
182
Managing suicidality within specialized care: A randomized controlled trial. 38
30771641 2019
183
Personality, personality disorders, and the process of change. 38
28946789 2019
184
Perceptual abnormalities in an ultra-high risk for psychosis population relationship to trauma and co-morbid disorder. 38
28792130 2019
185
Suicide Ideation in Adolescents Following Inpatient Hospitalization: Examination of Intensity and Lability Over 6 Months. 38
29577366 2019
186
Dangerous weapons or dangerous people? The temporal associations between gun violence and mental health. 38
30711465 2019
187
[Self-inflicted eye injury]. 38
29881876 2019
188
Understanding auditory verbal hallucinations in healthy individuals and individuals with psychiatric disorders. 38
30807972 2019
189
Perspective Change and Personality State Variability: An Argument for the Role of Self-Awareness and an Outlook on Bidirectionality (Commentary on Wundrack et al., 2018). 38
31162389 2019
190
Implicit and explicit self-concept of neuroticism in borderline personality disorder. 38
30896322 2019
191
Dialectical behaviour therapy (DBT) for forensic psychiatric patients: An Italian pilot study. 38
30648303 2019
192
Response inhibition in borderline personality disorder: Neural and behavioral correlates. 38
30772405 2019
193
FKBP5 gene variants and borderline personality disorder. 38
30711865 2019
194
Emotional Responsiveness in Borderline Personality Disorder: The Role of Basal Hyperarousal and Self-Reported Emotional Regulation. 38
30720601 2019
195
Patterns of altered regional brain glucose metabolism in borderline personality disorder and bipolar II disorder. 38
30552759 2019
196
Interpersonal Problems in Borderline Personality Disorder: Associations with Mentalizing, Emotion Regulation, and Impulsiveness. 38
30920937 2019
197
Carer perspectives of people diagnosed with borderline personality disorder: A scoping review of emergency care responses. 38
30998870 2019
198
Autobiographical memories, identity disturbance and brain functioning in patients with borderline personality disorder: An fMRI study. 38
30949597 2019
199
Momentary assessment of everyday physical pain in outpatients with borderline personality disorder. 38
30024195 2019
200
Disinhibited attachment behavior among infants of mothers with borderline personality disorder, depression, and no diagnosis. 38
30628799 2019
201
Emotional Competence and Coping Mechanisms in Croatian Women with Borderline Personality Disorder: the Role of Attachment. 38
30948694 2019
202
What Do Individuals With Borderline Personality Disorder Want From Treatment? A Study of Self-generated Treatment and Recovery Goals. 38
30849065 2019
203
Aberrant functional connectivity profiles of brain regions associated with salience and reward processing in female patients with borderline personality disorder. 38
30847803 2019
204
Age differences in DSM-IV borderline personality disorder symptom expression: Results from a national study using item response theory (IRT). 38
30579046 2019
205
Degree of Correspondence Between Retrospective and Proximal Reports of Borderline Personality Disorder Symptoms, Symptom Triggers, and Emotions. 38
30920939 2019
206
Getting Specific about Emotion and Self-Inflicted Injury: An Examination Across Emotion Processes in Borderline Personality Disorder. 38
30856367 2019
207
[Oxytocin and maltreatment potential : Influence of maternal depression, borderline personality disorder and experience of early childhood maltreatment]. 38
30725114 2019
208
Subjective emotional responses to IAPS pictures in patients with borderline personality disorder, cluster-C personality disorders, and non-patients. 38
31207857 2019
209
Mentalization-based treatment or psychodynamic treatment programmes for patients with borderline personality disorder - the impact of clinical severity. 38
29582581 2019
210
Longitudinal development of risk-taking and self-injurious behavior in association with late adolescent borderline personality disorder symptoms. 38
30641342 2019
211
Stuck in a negative me: fMRI study on the role of disturbed self-views in social feedback processing in borderline personality disorder. 38
30867073 2019
212
Stigma perpetuation at the interface of mental health care: a review to compare patient and clinician perspectives of stigma and borderline personality disorder. 38
30862201 2019
213
Which Problem Are We Addressing Today? The Utility of a Multifaceted Formulation Approach to a Complex Case. 38
30786736 2019
214
The Modulating Role of Self-Referential Stimuli and Processes in the Effect of Stress and Negative Emotion on Inhibition Processes in Borderline Personality Disorder: Proposition of a Model to Integrate the Self-Concept and Inhibition Processes. 38
30935039 2019
215
Differential Diagnosis between Anomalous Experiences and Dissociation Disorder Using the Dissociative Disorders Interview Schedule (DDIS). 38
30058948 2019
216
Mentalization-Based Treatment for Personality Disorders: Efficacy, Effectiveness, and New Developments. 38
30852694 2019
217
Neuropsychological and Criminological Features of Female Homicide Offenders. 38
30231300 2019
218
Pierced identities: Body modification, borderline personality features, identity, and self-concept disturbances. 38
30113185 2019
219
Parent-Adolescent Concordance in Borderline Pathology and why it Matters. 38
30062612 2019
220
Neural Correlates of Affective Disturbances: A Comparative Meta-analysis of Negative Affect Processing in Borderline Personality Disorder, Major Depressive Disorder, and Posttraumatic Stress Disorder. 38
30581154 2019
221
Acceptance and present-moment awareness in psychiatric disorders: Is mindfulness mood dependent? 38
30682558 2019
222
Effectiveness of Electroconvulsive Therapy in Patients With Major Depressive Disorder and Comorbid Borderline Personality Disorder. 38
30113988 2019
223
Relations of mindfulness facets with psychological symptoms among individuals with a diagnosis of obsessive-compulsive disorder, major depressive disorder, or borderline personality disorder. 38
29575447 2019
224
Genetic risk for bipolar disorder and psychopathology from childhood to early adulthood. 38
30611060 2019
225
Pharmacologic Treatment of Borderline Personality Disorder. 38
30811158 2019
226
Risk Factors for Borderline Personality Disorder in Adolescents. 38
30920936 2019
227
Assessing self-reported empathy and altruism in patients suffering from enduring borderline personality disorder. 38
30819534 2019
228
Crying in borderline personality disorder patients. 38
30640050 2019
229
Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review. 38
30676404 2019
230
Residential eating disorder outcomes associated with screening positive for substance use disorder and borderline personality disorder. 38
30746736 2019
231
Long-term clinical and functional course of borderline personality disorder: A meta-analysis of prospective studies. 38
30599336 2019
232
Disorganized Attachment Interactions Among Young Adults With Borderline Personality Disorder, Other Diagnoses, and No Diagnosis. 38
30785838 2019
233
The Clinical Significance of Subthreshold Borderline Personality Disorder Features in Outpatient Youth. 38
30036169 2019
234
Differential Change of Borderline Personality Disorder Traits During Dialectical Behavior Therapy for Adolescents. 38
30036173 2019
235
Dependency, mood instability, and inconsequence traits for discriminating borderline personality disorder. 38
30843964 2019
236
Metacognitive improvement and symptom change in a 3-month treatment for borderline personality disorder. 38
30712326 2019
237
Emotions at the border: Increased punishment behavior during fair interpersonal exchanges in borderline personality disorder. 38
30714797 2019
238
Prescribing Practices for Patients With Borderline Personality Disorder During Psychiatric Hospitalizations. 38
30742548 2019
239
Are Impairments in Theory of Mind Specific to Borderline Personality Disorder? 38
30785865 2019
240
Borderline personality disorder traits and suicide risk: The mediating role of insomnia and nightmares. 38
30326346 2019
241
Borderline personality disorder or a disorder within the schizophrenia spectrum? A psychopathological study. 38
30600641 2019
242
Multimodal assessment of emotional reactivity and regulation in response to social rejection among self-harming adults with and without borderline personality disorder. 38
30816776 2019
243
An exploration of self-compassion and self-criticism in the context of personal recovery from borderline personality disorder. 38
30226078 2019
244
Attitudes of Mental Health Staff Toward Patients With Borderline Personality Disorder: An Italian Cross-Sectional Multisite Study. 38
30785861 2019
245
Borderline Personality Disorder Symptom Comorbidity Within a High Externalizing Sample: Relationship to the Internalizing-Externalizing Dimensional Structure of Psychopathology. 38
30730780 2019
246
The Experience of Maltreatment in Young Children Whose Mothers Have Borderline Personality Disorder: Reflections in Their Narrative Representations. 38
30742556 2019
247
Parenting in Patients with Borderline Personality Disorder, Sequelae for the Offspring and Approaches to Treatment and Prevention. 38
30729325 2019
248
Day hospital versus intensive out-patient mentalisation-based treatment for borderline personality disorder: multicentre randomised clinical trial. 38
30791963 2019
249
Bridging the Gap Between Remission and Recovery in BPD: Qualitative Versus Quantitative Perspectives. 38
30785863 2019
250
Predictors of Slower Time-to-Cessation of Individual Therapy for Borderline Patients Over 16 Years of Prospective Follow-Up. 38
29505389 2019
251
Rapid brain responses to affective pictures indicate dimensions of trauma-related psychopathology in adolescents. 38
30807662 2019
252
The concurrent validity of a Web-based self-report assessment for personality disorders. 38
30592174 2019
253
When Trust Does Not Come Easily: Negative Emotional Information Unduly Influences Trustworthiness Appraisals for Individuals With Borderline Personality Features. 38
30742543 2019
254
[Relationship difficulties with borderline patients in five questions]. 38
30724534 2019
255
The within-person effects of validation and invalidation on in-session changes in affect. 38
30714798 2019
256
Uncovering general, shared, and unique temporal patterns in ambulatory assessment data. 38
30124300 2019
257
Juggling thoughts and feelings: How do female patients with borderline symptomology and substance use disorder experience change in mentalization-based treatment? 38
28513339 2019
258
Evaluation of a Dialectical Behavior Therapy Psychiatry Residency Training Program. 38
30315500 2019
259
Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits. 38
30406413 2019
260
Endoscopic removal of a gastric pharmacobezoar induced by clomipramine, lorazepam, and domperidone overdose: a case report. 38
30808405 2019
261
[Attention-deficit/hyperactivity disorder (ADHD) in adult psychiatry: Data on 12-month prevalence, risk factors and comorbidity]. 38
29490380 2019
262
Impulsivity and its association with childhood trauma experiences across bipolar disorder, attention deficit hyperactivity disorder and borderline personality disorder. 38
30336349 2019
263
Pathological Narcissism: A Study of Burden on Partners and Family. 38
30730784 2019
264
Suicidal Imagery in Borderline Personality Disorder and Major Depressive Disorder. 38
30785849 2019
265
Change of Emotional Experience in Major Depression and Borderline Personality Disorder During Psychotherapy: Associations With Depression Severity and Personality Functioning. 38
30785864 2019
266
10-Year Outcome of Suicidal Behavior in Borderline Personality Disorder. 38
29469667 2019
267
Abandonment Psychotherapy and Psychosocial Functioning Among Suicidal Patients With Borderline Personality Disorder: A 3-Year Naturalistic Follow-Up. 38
30785852 2019
268
Differentiating bipolar disorder from borderline personality disorder: Diagnostic accuracy of the difficulty in emotion regulation scale and personality inventory for DSM-5. 38
30699870 2019
269
Reviewing the clinical significance of 'fear of abandonment' in borderline personality disorder. 38
30403145 2019
270
Mindreading abilities and borderline personality disorder: A comprehensive assessment using the Theory of Mind Assessment Scale. 38
30616131 2019
271
Gender differences and similarities in aggression, suicidal behaviour, and psychiatric comorbidity in borderline personality disorder. 38
30353921 2019
272
Repetitive Transcranial Magnetic Stimulation in the Treatment of a Difficult to Treat Condition, Borderline Personality Disorder. 38
30633728 2019
273
The Role of Interactional Agreeableness in Responsive Treatments for Patients With Borderline Personality Disorder. 38
30650009 2019
274
Exploring the boundaries between borderline personality disorder and suicidal behavior disorder. 38
30673835 2019
275
Relations of Maternal Borderline Personality Disorder Features With Preschooler Executive Functioning and Theory of Mind. 38
30689501 2019
276
Biased Attention to Facial Expressions of Ambiguous Emotions in Borderline Personality Disorder: An Eye-Tracking Study. 38
30689505 2019
277
The Relationship Among Shame, Nonsuicidal Self-Injury, and Suicidal Behaviors in Borderline Personality Disorder. 38
30654709 2019
278
Moving Toward Connectedness - A Qualitative Study of Recovery Processes for People With Borderline Personality Disorder. 38
30873097 2019
279
Effect of negative valence on assessment of self-relevance in female patients with borderline personality disorder. 38
30629628 2019
280
Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulation. 38
30591402 2019
281
Longitudinal associations between non-suicidal self-injury and borderline personality disorder in adolescents: a literature review. 38
30783532 2019
282
Neuropsychological findings in recent onset schizophrenia and borderline personality disorder: a comparison study. 38
30724326 2019
283
Hypothalamic-pituitary-adrenal axis functioning in borderline personality disorder: A meta-analysis. 38
30500331 2019
284
Effects of Childhood Maltreatment on Social Cognition and Brain Functional Connectivity in Borderline Personality Disorder Patients. 38
30988667 2019
285
A randomized controlled trial of a mentalization-based intervention (MBT-FACTS) for families of people with borderline personality disorder. 38
29999394 2019
286
Effects of transcranial direct current stimulation on the cognitive control of negative stimuli in borderline personality disorder. 38
30674987 2019
287
Low positive affect display mediates the association between borderline personality disorder and negative evaluations at zero acquaintance. 38
30867910 2019
288
Rejection Sensitivity and Borderline Personality Disorder Features: The Mediating Roles of Attachment Anxiety, Need to Belong, and Self-Criticism. 38
30650007 2019
289
Interdiagnostician Reliability of the DSM-5 Section II and Section III Alternative Model Criteria for Borderline Personality Disorder. 38
30650010 2019
290
Women With Borderline Personality Disorder Show Reduced Identification of Emotional Facial Expressions and a Heightened Negativity Bias. 38
30689504 2019
291
The Therapeutic Alliance Over 10 Sessions of Therapy for Borderline Personality Disorder: Agreement and Congruence Analysis and Relation to Outcome. 38
30689513 2019
292
Number of Borderline Personality Disorder Criteria and Depression Predict Poor Functioning and Quality of Life in Outpatient Youth. 38
30689518 2019
293
Emotional impulsivity is connected to suicide attempts and health care utilization in patients with borderline personality disorder. 38
30503219 2019
294
Effects of Therapeutic Alliance and Metacognition on Outcome in a Brief Psychological Treatment for Borderline Personality Disorder. 38